CORRIGENDUM: A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study)

Yasuo Okumura; Ikuo Fukuda; Mashio Nakamura; Norikazu Yamada; Morimasa Takayama; Hideaki Maeda; Takeshi Yamashita; Takanori Ikeda; Makoto Mo; Takao Kobayashi; Akihiro Niwa; Hiroshi Matsuo; Hiroyoshi Yokoi; Masatoshi Koga; Tsutomu Yamazaki; Atsushi Hirayama; on behalf of the J’xactly Investigators

doi:10.1253/circj.CJ-66-0190

Corrigendum

CORRIGENDUM: A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study)

Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda, Takeshi Yamashita, Takanori Ikeda, Makoto Mo, Takao Kobayashi, Akihiro Niwa, Hiroshi Matsuo, Hiroyoshi Yokoi, Masatoshi Koga, Tsutomu Yamazaki, Atsushi Hirayama, on behalf of the J’xactly Investigators

Author information

Yasuo Okumura
Ikuo Fukuda
Mashio Nakamura
Norikazu Yamada
Morimasa Takayama
Hideaki Maeda
Takeshi Yamashita
Takanori Ikeda
Makoto Mo
Takao Kobayashi
Akihiro Niwa
Hiroshi Matsuo
Hiroyoshi Yokoi
Masatoshi Koga
Tsutomu Yamazaki
Atsushi Hirayama
on behalf of the J’xactly Investigators

JOURNAL OPEN ACCESS FULL-TEXT HTML

2021 Volume 85 Issue 3 Pages 330-

DOI https://doi.org/10.1253/circj.CJ-66-0190

Article (84-11 pp. 1912-1921)

Details

The authors apologize for the written mistakes in the Results section. Corrections are shown below, with the corrected number circled by red square.

Page 1917, Figure 3A

Incorrect: 13 (3.5%)

Correct: 20 (3.5%)

Corresponding author

Register with J-STAGE for free!